Joint funding programmes

Author

Christa Ivanova, PhD

Publication Date

September 14, 2021

Keywords

joint funding programmes

HE funding

ERA PerMed

early diagnosis

JPIAMR joint transnational call

microbial resistance

ERA-NET NEURON JTC 2022

cerebrovascular diseases

collaborative research

Your microfluidic SME partner for Horizon Europe

We take care of microfluidic engineering, work on valorization and optimize the proposal with you 

International joint funding programmes for collaborative research

Aside from the Horizon Europe funding program established by the European Commission, there are several joint funding initiatives where national funding bodies collaborate to support international collaboration between academia and industry. 

The participating countries are determined individually for each call since the national funding bodies enter agreements with the joint program. Several programs are under the ERA-NET Cofund scheme, which the European Commission created. 

This instrument is designed in a way that it “tops up” funding of national funding organizations. Increasing the overall budget facilitates the creation of project calls and, thus, international collaboration. 

This page gives some examples of Joint Funding Programmes under the ERA-NET umbrella. 

For more details on eligibility, please carefully study the conditions of each call, as they may vary. All calls are also listed in our Call Calendar 2023, which you can download on this page.

ERA PerMed Joint Funding Programme

ERA PerMed

The ERA PerMed call 2022 targets developments in personalized medicine to foster collaborations with an emphasis on early diagnosis and prevention. To be successfully implemented, the projects must involve patients, stakeholders, and end-users and use and create new databases.

JPIAMR joint transnational call Joint Funding Programme

JPIAMR joint transnational call

Disrupting drug Resistance Using Innovative Design, or short – DRUID – is the 14th JPIAMR transnational call for research projects within the ERA-NET JPIAMR-ACTION.

The call focuses on combating microbial resistance in humans and plants and deals with bacteria, fungi, and viral infections.

The aim is to find new defense strategies with existing means, such as unique combinations of antimicrobial agents.

NEURON Joint Funding Programme

ERA-NET NEURON JTC 2022

The JTC NEURON call of 2022 will fund research projects on cerebrovascular diseases.

Cerebral small vessels and the malfunction of brain barriers, as well as other changes such as immune responses, have been identified as conditions frequently associated with the development of stroke and vascular cognitive dysfunction.

Projects funded under this call should focus on preclinical and clinical research addressing the pathophysiology and therapeutic developments for stroke and other cerebrovascular diseases.

We will be glad to participate in your project. Visit our dedicated webpage to learn more about our expertise as H2020 and Horizon Europe partner!

Curious about the calls currently open?

Download the MIC Horizon Europe 2025 Calls Calendar:

We are particularly interested in the following calls but remain open to any collaboration!

  • EIC Work Programme that supports all stages from R&D to industry for game-changing innovations
  • Horizon Europe RIA Calls, explicitly focusing on health and food, bioeconomy, natural resources, agriculture, and environment

Some of our funded projects

ACDC_artificial_cell_microfluidics-Elvesys-capsules

Artificial cells with distributed cores to decipher protein function

FIDA_flow-control_fluid-handling-Elveflow-virus

Complex and automated fluid handling in a disruptive antibody analytical platform

Soil-on-Chip-Active-Matter-Elveflow-research-projects

Microfluidic soil-on-chip devices in the study of microbial communities

Check the Horizon Europe tips and tricks

FAQ - Joint funding programmes

Q1. So what are joint funding programmes?

They consist of the calls in which European and national (or regional) funders combine resources and organize a coordinated competition. Notions are compared based on common preconditions, and then each funder that is involved at the time funds its beneficiaries. To a research team, it is like one phone call; in other words, there is money coming in through various channels.

 

Q2. Which are the major types of joint programmes to which I must be familiar?

Three buckets cover the majority of circumstances:

 Co-written research agendas (co-funded European Partnerships).

 Transnational joint calls (scientific networks assembling periodic calls in countries).

 Bilateral/ multilateral joint calls (two or more agencies coordinating a topic and an agenda).

All of them are based on the logic of a single evaluation and multiple payers.

 

Q3. Who does it pay? And do all the partners enjoy EU funding?

Eligibility is two-layered. To begin with, the consortium should comply with the transnational requirements of the call (e.g., three or more countries). Second, the partners must meet the national regulations (legal form, TRL bracket, cost model, caps) of their respective funders. Not everyone receives EU funds directly: many joint calls are funded with national money in accordance with a common work programme. It is not uncommon for a university in country A and an SME in country B to have their national agencies as funders, but under a single Grant Agreement or a series of national contracts, all working together.

 

Q4. What is the budget and reimbursement rates process?

Budgets are released in the form of a world envelope, with a ring-fenced sub-budget and its reimbursement rate (e.g., 100% for universities, 50-80% for companies, research vs. development). You apply once; if successful, every beneficiary enters into an agreement with their national funder at local rates. Check caps should always be per partner (maximum per project or country is typical).

 

Q5. What maturity technology releases (TRLs) are joint calls typically interested in?

TRL 2-6 (research to validation in a relevant environment) is mostly funded by most joint programmes. Some are higher-leverage (pilot lines, demonstrated at TRL 6-7), and some are completely exploratory (TRL 1-3). When there is an indication of a Partnership, as stated in a call aligned with a Strategic Research and Innovation Agenda, anticipate an evident TRL corridor and compulsory milestones.

 

Q6. What is the appearance of evaluation- a single panel or multiple panels?

A single international panel usually compiles a ranking list. The proposal has to be funded; this requires it to pass the scientific bar and fit within each country’s remaining budget. A project may be fundable on an international scale and unfunded if particular national funds are depleted. A powerful, balanced effort between the partners would prevent this edge case.

 

Q7. Any common traps during the construction of a consortium around a joint programme?

Two, two times: (1) the partners selected based on prestige, but not based on workshare – the reviewers will notice where work does not fit the competencies; (2) failing to consider national eligibility peculiarities (e.g., indirect cost rates, subcontracting limit, industrial research vs. experimental development definition). Week saved by making a rapid pre-check with every National Contact Point and funder.

 

Q8. What is the difference between timelines and documents and a typical Horizon Europe RIA?

They are also lighter in front (as many as 20-30 pages of the main narrative), although they include national annexes by partner (budget tables, ethics, state-aid declarations). Once the selection is made, the contracting stage may be parallel across countries, and this adds overhead to coordination. Optimize a start date and freeze a shared data management and IP framework.

 

Q9. What is special in joint calls (and in microfluidics in particular) with regard to proposals?

Clarity at interfaces. They want to see: quantified KPIs (flow stability, limit of detection, sample-to-answer time, throughput), a clean separation between method development and application validation, and clear fallbacks (alternative channel geometry/materials, backup bonding/packaging, redundant sensing). A prototype plan will create a trusting plan; a staged prototype plan: bench rig, integrated module, application demo.

 

Q10. So what part does a microfluidics SME play in a joint programme?

By converting ideas into hardware that is reliable and testable in a short period of time. Microfluidics Innovation Center (MIC) develops chips (polymer, silicon, glass), manufactures prototypes, assembles sensors and controls, and provides turnkey experimental systems. In collective calls, it reduces iteration time and removes risks to deliverables through effective fluid management and automation. In a variety of European consortia, our presence has increased the odds of proposal success by about 2 times that of official baselines, not least through enhanced KPIs, integration discipline, and believable exploitation packs.